Both can be present: anti‑SSA (anti‑Ro) and anti‑SSB (anti‑La). Anti‑SSA/Ro is more commonly detected and more sensitive for Sjögren’s; anti‑SSB/La is less frequent and often occurs with SSA. Anti‑SSA may appear alone; SSB rarely occurs without SSA. Their presence supports diagnosis and can affect prognosis and complications (for example, neonatal lupus in pregnancy).

Anti‑SSA (anti‑Ro) autoantibodies are most commonly associated with Sjögren’s syndrome and systemic lupus erythematosus (including subacute cutaneous lupus). They can cross the placenta, causing neonatal lupus and congenital heart block. Anti‑SSA is used as a diagnostic and prognostic serologic marker, often present in primary and secondary Sjögren’s and in a subset of SLE patients.

SS‑A (also called anti‑Ro) refers to autoantibodies against Ro/SSA proteins commonly found in Sjögren’s syndrome and systemic lupus erythematosus. Their presence supports diagnosis and may correlate with more systemic features (skin, lung, joint involvement). In pregnancy, maternal SS‑A antibodies can cross the placenta and increase risk of neonatal lupus and congenital heart block, so monitoring is recommended.

Sjögren’s isn’t an automatic SSA listing. It can qualify if its systemic complications or functional limits meet a Blue Book listing (e.g., inflammatory arthritis, neurological or organ-specific criteria) or if a claimant’s residual functional capacity shows they cannot perform substantial gainful activity. Detailed medical records, objective tests, treatment history, and statements about daily limitations are essential when applying or appealing.

Anti‑Ro (SS‑A) and anti‑La (SS‑B) are autoantibodies against cellular ribonucleoproteins. They help diagnose autoimmune connective‑tissue diseases—especially Sjögren’s syndrome and systemic lupus erythematosus—and can predict specific features (skin photosensitivity, dry eyes/mouth). In pregnancy, their presence raises concern for neonatal lupus and congenital heart block, prompting closer monitoring and management.

Sjögren’s syndrome is classified as a chronic systemic autoimmune disorder that primarily targets the body’s exocrine glands, causing dry eyes and dry mouth (sicca). It’s considered a rheumatic or connective tissue autoimmune disease and may occur alone (primary) or with other autoimmune conditions such as rheumatoid arthritis or lupus (secondary).